Invention Grant
- Patent Title: 19-NOR neuroactive steroids and methods of use thereof
-
Application No.: US16440527Application Date: 2019-06-13
-
Publication No.: US11261211B2Publication Date: 2022-03-01
- Inventor: Gabriel Martinez Botella , Boyd L. Harrison , Albert Jean Robichaud , Francesco G. Salituro , Richard Thomas Beresis
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Honigman LLP
- Agent Kathryn D. Doyle; Jonathan P. O'Brien
- Priority: WOPCT/CN2013/074312 20130417
- Main IPC: C07J43/00
- IPC: C07J43/00 ; C07J21/00 ; C07J3/00 ; C07J7/00 ; C07J13/00 ; C07J31/00

Abstract:
Provided herein are 3,3-disubstituted 19-nor-steroidal compounds according to Formula (1): and pharmaceutical compositions thereof. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, tinnitus, and status epilepticus.
Public/Granted literature
- US20200048300A1 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF Public/Granted day:2020-02-13
Information query